CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.46 ($346,443)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.69 ($368,987)
- 4 Open-market buy Vice Chairman & CTO bought 10 shares at $3.73 ($37)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $3.62 ($723,927)
- 4 Open-market buy SVP OPKO; Exec Chairman BRLI bought 50,000 shares at $3.81 ($190,500)
- 4 Open-market buy CEO & Chairman bought 400,000 shares at an average $3.64 ($1,455,972)
- 4 Open-market buy CEO & Chairman bought 75,000 shares at an average $3.65 ($273,745)
- 4 Open-market buy CEO & Chairman bought 75,000 shares at an average $3.84 ($287,743)
- 4 Open-market buy CEO & Chairman bought 25,000 shares at an average $3.91 ($97,783)
- 4 Open-market buy CEO & Chairman bought 25,000 shares at an average $3.94 ($98,481)
- 4 Open-market buy CEO & Chairman bought 300,000 shares at an average $3.91 ($1,173,841)
- 4 Derivatives Options or other derivatives
Page 10 of 106 · 2,118 filings